WMG Financial Advisors’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,726
Closed -$306K 137
2025
Q3
$306K Sell
10,726
-94
-0.9% -$2.56K 0.1% 141
2025
Q2
$277K Sell
10,820
-2,075
-16% -$52.5K 0.1% 143
2025
Q1
$354K Sell
12,895
-398
-3% -$11K 0.15% 94
2024
Q4
$358K Sell
13,293
-93
-0.7% -$2.61K 0.15% 98
2024
Q3
$386K Hold
13,386
0.17% 82
2024
Q2
$365K Sell
13,386
-2,153
-14% -$57.7K 0.19% 77
2024
Q1
$435K Sell
15,539
-1,539
-9% -$42.4K 0.25% 73
2023
Q4
$455K Sell
17,078
-79
-0.5% -$1.99K 0.3% 65
2023
Q3
$439K Sell
17,157
-22,036
-56% -$583K 0.37% 57
2023
Q2
$1.03M Sell
39,193
-12,266
-24% -$324K 0.76% 29
2023
Q1
$1.34M Buy
51,459
+11,386
+28% +$305K 1.11% 24
2022
Q4
$1.1M Sell
40,073
-1,894
-5% -$50.4K 0.94% 31
2022
Q3
$1.01M Buy
41,967
+9,800
+30% +$253K 0.91% 33
2022
Q2
$848K Buy
+32,167
New +$850K 0.74% 38

Other funds holding FTXH